STUDIES & TRIALS
Panacea is passionate about providing products made by nature using formulas backed by science.
There are currently no human clinical open for enrollment.
Evaluation of CBD in Canine Age-Related Movement Disorders
An open label study to evaluate the ability of cannabidiol to help pets with movement disorders like stiff or weak joints, sore muscles, pain, recumbency, lack of interest in activity or exercise, and general lack of movement.
Enrollment open until Feb. 28, 2023.
MORE INFO & ENROLLMENT INSTRUCTIONS
WHY ARE CLINICAL TRIALS & STUDIES FOR CBD IMPORTANT?
CBD is a naturally occurring substance found in the hemp plant, which humans have been in contact with for centuries. However, because it was outlawed for much of the last century up until 2018, we know relatively little about its potential applications in modern medicine.
Promising CBD medical discoveries point to the possibility that it might be useful for a wide range of conditions throughout life. Proponents of CBD, or cannabidiol claim that it can be used to treat conditions such as chronic pain, inflammation, migraines, epilepsy, autoimmune diseases, depression and anxiety, and more.
Further CBD clinical trials are needed to fully understand the precise ways in which CBD works in our bodies. If it proves to be as promising as it seems, this natural medicine has the potential to change the medical and pharmaceutical landscape forever.
Panacea Life Sciences Cannabinoid Research Center at Colorado State University
Made possible by a $1.5 million gift from CSU alumna and Panacea’s CEO, Leslie Buttorff, the center boasts state-of-the-art chemical separation and analysis instrumentation that enables foundational research in the chemistry of cannabinoids. The overarching goal is to extend our knowledge of how cannabis extracts affect human and animal health.
The first three studies at the center are underway, examining cannabidiol’s effects on Inflammatory Bowel Disease (IBS), dementia and chronic pelvic pain.
Panacea’s Scientific Advisory Board
Panacea’s Scientific Advisory Board (“SAB”) is comprised of six carefully selected key opinion leaders and subject matter experts from a variety of areas of studies and backgrounds including skincare, veterinary, chemical and biological engineering, agronomy, and medical.
As the company makes their push toward producing more purposeful biomedical cannabinoid medicine products for both humans and pets, the SAB meets quarterly to provide external and objective guidance on cannabinoid study design, product and formula validation, workshops, meetings, panels, and more.
WHAT RESEARCH CURRENTLY EXISTS AROUND CBD?
Because CBD has only recently entered the medical mainstream, there are still many unanswered questions to be explored. Early research focused on the role of cannabinoid receptors in the brain in perceiving and processing CBD, as well as its effect on the brain’s production of dopamine.
Over the last few years, doctors have launched small-scale CBD studies and CBD clinical trials to find other potential uses for the compound. We DO know that CBD CBD interacts with neuroreceptors in the body’s endocannabinoid system, which sends signals between your cells to help regulate your movement, mood, homeostasis and immune system. This means CBD has major potential for treating a variety of disorders and ailments.
In just a few short years, there have already been hundreds of studies exploring the benefits that CBD can provide. Namely, CBD has been proven to help treat epilepsy, offset anxiety and depression, treat opioid addiction, alleviate unmanageable pain, protect against neurological diseases, and inhibit arthritis symptoms.*